Harry Skip Kiil sold $5.1M of MDT
EVP & President Cardiovascular at Medtronic plc. 52,524 shares at an average of $97.71, traded Feb 19, 2026, filed Feb 26, 2026.
Score components
- +15RoleOfficer
- +25Trade size$5.1M at market
- +20Share of holdings soldSold 62% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.5%, 3m -21.5%, 6m -5.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001708062-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | MOption exercise Ordinary Shares | +30,568 | $93.08 | $2.8M | 64,984 | Feb 26, 2026 |
| Feb 19, 2026 | MOption exercise Ordinary Shares | +19,923 | $87.76 | $1.7M | 84,907 | Feb 26, 2026 |
| Feb 19, 2026 | MOption exercise Ordinary Shares | +385 | $80.00 | $31k | 85,292 | Feb 26, 2026 |
| Feb 19, 2026 | SOpen-market sale Ordinary Shares | -1,648 | $97.86 | $161k | 83,644 | Feb 26, 2026 |
| Feb 19, 2026 | SOpen-market sale Ordinary Shares | -30,568 | $97.66 | $3.0M | 53,076 | Feb 26, 2026 |
| Feb 19, 2026 | SOpen-market sale Ordinary Shares | -19,255 | $97.77 | $1.9M | 33,821 | Feb 26, 2026 |
| Feb 19, 2026 | SOpen-market sale Ordinary Shares | -668 | $97.83 | $65k | 33,153 | Feb 26, 2026 |
| Feb 19, 2026 | SOpen-market sale Ordinary Shares | -385 | $97.82 | $38k | 32,768 | Feb 26, 2026 |
| Feb 19, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -30,568 | $0.00 | $0 | 11,606 | Feb 26, 2026 |
| Feb 19, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -19,923 | $0.00 | $0 | 18,926 | Feb 26, 2026 |
| Feb 19, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -385 | $0.00 | $0 | 1,155 | Feb 26, 2026 |
Related signals
Other insiders at Medtronic plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $139k 1,483 shares | -3% | |
| 8Weak | Medtronic plc | Matthew R. Walter SVP, Chief HR Officer | $258k 3,102 shares | -8% | |
| 35Weak | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $337k 4,189 shares | -10% | |
| 50Moderate | MDTsell Medtronic plc | Gregory L Smith EVP Global Ops & Supply Chain | $3.1M 30,000 shares | -39% | |
| 42Moderate | MDTsell Medtronic plc | Harry Skip Kiil EVP & President Cardiovascular | $788k 8,605 shares | -19% | |
| 40Moderate | MDTbuy Medtronic plc | William R Jellison director | $463k 5,000 shares | - | |
| 40Moderate | MDTsell Medtronic plc | Geoffrey Martha Chairman and CEO | $1.6M 19,113 shares | -12% | |
| 23Weak | MDTsell Medtronic plc | Michael Marinaro EVP & President, Surgical OU | $71k 854 shares | -3% | |
| 35Weak | MDTsell Medtronic plc | Sean Salmon EVP & President Cardiovascular | $2.6M 30,695 shares | -39% | |
| 16Weak | Medtronic plc | Brett A. Wall EVP & Pres Neuroscience | $411k 4,997 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.